Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Macadamia Nut-Specific IgE Levels Predict Anaphylaxis

By LabMedica International staff writers
Posted on 24 Oct 2022

Proteins residing in tree nuts are mistakenly treated as harmful by the immune system, which then releases antibodies to combat them. More...

Chemical reaction triggers within protein substances, mast cells and histamines produced by immune system resulting in allergic symptoms.

Tree nut allergy symptoms typically occur within minutes of ingestion and can range from hives to anaphylaxis, a potentially life-threatening reaction that impairs breathing and can send the body into shock. In terms of prevalence, less than 5% of people in the USA who are sensitized to tree nuts are allergic to macadamia nuts.

Allergists and immunologists from the Sagamihara National Hospital (Sagamihara, Japan) included in a study 41 children (71% boys; median age, 7.7 years) with suspected macadamia nut allergy who visited the hospital between April 2012 and July 2021. Patient interviews and a three-level stepwise oral food challenge (OFC) found that 21 of these children had an allergy and 20 did not. The study aimed to investigate macadamia nut-specific immunoglobulin E (Md-sIgE).

Eight of the allergic children (38%) had experienced anaphylaxis. Symptoms included generalized urticaria, cough, wheezing, throat pruritus, abdominal pain, lip swelling and recurrent emesis. Among the other 13 allergic children (62%) who did not experience anaphylaxis, symptoms included face swelling, localized or generalized urticaria, intermittent cough, lip swelling and throat pruritus. None of the allergic children experienced mild subjective symptoms that were localized to the oral cavity.

The investigators collected blood samples from all patients within 12 months of the OFC or the allergic reaction to macadamia nut. The median level of macadamia nut-specific IgE (Md-sIgE) for the full cohort was 2.23 kUA/L. The children with allergy and anaphylaxis had higher Md-sIgE levels (median, 7.97 kUA/L; interquartile range [IQR], 5.08-23.3) than the children with allergy who did not have anaphylaxis (median, 1.92 kUA/L; IQR, 0.83-6.04) and those who did not have allergy (median, 1.9 kUA/L; IQR, 0.56-2.78). The difference between the latter two groups did not reach significance.

Based on receiver operating characteristic analysis for predicting anaphylaxis using Md-sIgE levels, the researchers found that the area under the curve of Md-sIgE was 0.92 (95% CI, 0.83-1) with an optimal cutoff value of 3.76 kUA/L. Eight of the 16 children (50%) with Md-sIgE levels over this level and none of the children with levels under that benchmark developed anaphylaxis.

Also, positive predictive values for anaphylaxis included 5% for 1.8 kUA/L, 10% for 2.75 kUA/L, 20% for 4.36 kUA/L, 80% for 21.06 kUA/L, 90% for 33.38 kUA/L and 95% for 51.04 kUA/L, with a maximum value of 38.3 kUA/L. About one-third of the children with sIgE values under 3.76 kUA/L had a macadamia nut allergy with no anaphylaxis, indicating that OFC could be safe for them.

The authors concluded that Md-sIgE levels were useful in predicting anaphylaxis. Above the cut-off value, they emphasized paying careful attention to the risk of anaphylaxis. The study was first published on September 18, 2022 in the journal Pediatric Allergy and Immunology.

Related Links:
Sagamihara National Hospital


New
Gold Member
Blood Gas Analyzer
Stat Profile pHOx
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Gram-Negative Blood Culture Assay
LIAISON PLEX Gram-Negative Blood Culture Assay
New
Gold Member
Hematology Analyzer
Medonic M32B
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The ONC IN-CYT platform leverages cross indication biomarker cyto-signatures (Photo courtesy of OraLiva)

AI-Powered Cytology Tool Detects Early Signs of Oral Cancer

Each year, 54,000 Americans are diagnosed with oral cancer, yet only 28% of cases are identified at an early stage, when the five-year survival rate exceeds 85%. Most diagnoses occur in later stages, when... Read more

Hematology

view channel
Image: The microfluidic device for passive separation of platelet-rich plasma from whole blood (Photo courtesy of University of the Basque Country)

Portable and Disposable Device Obtains Platelet-Rich Plasma Without Complex Equipment

Platelet-rich plasma (PRP) plays a crucial role in regenerative medicine due to its ability to accelerate healing and repair tissue. However, obtaining PRP traditionally requires expensive centrifugation... Read more

Pathology

view channel
Image: Researchers have developed a novel method to analyze tumor growth rates (Photo courtesy of Adobe Stock)

Novel Method To Analyze Tumor Growth Rates Helps Tracks Progression Between Diagnosis and Surgery

Patients diagnosed with breast cancer often worry about how quickly their tumors grow while they wait for surgery, and whether delays in treatment might allow the disease to spread beyond the point of cure.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.